Atea Pharmaceuticals's market cap is currently $265.21M. The company's EPS TTM is $-2.072; its P/E ratio is ―; Atea Pharmaceuticals is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 351.37M	$ 48.63M	$ 0.00
Gross Profit	$ -70.09M	$ -260.00K	$ 351.34M	$ 48.61M	$ -17.00K
Operating Income	$ -164.16M	$ -130.65M	$ 138.38M	$ -11.03M	$ -14.61M
EBITDA	$ -119.59M	$ -110.84M	$ 138.41M	$ -11.01M	$ -14.59M
Net Income	$ -135.96M	$ -115.91M	$ 121.19M	$ -10.86M	$ -13.46M
Balance Sheet
Cash & Short-Term Investments	$ 578.11M	$ 646.71M	$ 764.38M	$ 850.12M	$ 21.66M
Total Assets	$ 594.97M	$ 666.71M	$ 772.89M	$ 863.63M	$ 22.07M
Total Debt	$ 2.40M	$ 3.12M	$ 197.00K	$ 0.00	$ 0.00
Net Debt	$ -141.42M	$ -643.59M	$ -764.18M	$ -850.12M	$ -21.66M
Total Liabilities	$ 39.78M	$ 26.14M	$ 62.81M	$ 315.83M	$ 71.64M
Stockholders' Equity	$ 555.19M	$ 640.57M	$ 710.08M	$ 547.80M	$ -49.57M
Cash Flow
Free Cash Flow	$ -85.39M	$ -122.92M	$ -87.01M	$ 296.71M	$ -12.82M
Operating Cash Flow	$ -85.39M	$ -120.98M	$ -87.00M	$ 296.73M	$ -12.81M
Investing Cash Flow	$ 40.30M	$ -455.41M	$ -4.00K	$ -26.00K	$ -2.00K
Financing Cash Flow	$ 257.00K	$ 370.00K	$ 1.47M	$ 531.75M	$ -15.00K

Currency in USD

Atea Pharmaceuticals Earnings and Revenue History

Income Statement >

Atea Pharmaceuticals Debt to Assets

Balance Sheet >

Atea Pharmaceuticals Cash Flow

Cash Flow >

Atea Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing